InvestorsHub Logo
icon url

Bluehorseshoe66

11/16/20 7:22 PM

#16305 RE: Pennsy #16304

Please Read, As of November 2020, Moderna was valued at $35 billion, and while none of its drugs had been approved, its COVID-19 vaccine candidate was close to obtaining emergency use authorization.[6][13]

That is amazing to me!